CN101254214A - Chinese medicine catablasm base material - Google Patents

Chinese medicine catablasm base material Download PDF

Info

Publication number
CN101254214A
CN101254214A CNA2007100204174A CN200710020417A CN101254214A CN 101254214 A CN101254214 A CN 101254214A CN A2007100204174 A CNA2007100204174 A CN A2007100204174A CN 200710020417 A CN200710020417 A CN 200710020417A CN 101254214 A CN101254214 A CN 101254214A
Authority
CN
China
Prior art keywords
parts
matrix
good
chinese medicinal
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100204174A
Other languages
Chinese (zh)
Other versions
CN101254214B (en
Inventor
耿同全
汤为民
朱文英
潘金火
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu 707 Natural Pharmaceutical Co Ltd
Original Assignee
Jiangsu 707 Natural Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu 707 Natural Pharmaceutical Co Ltd filed Critical Jiangsu 707 Natural Pharmaceutical Co Ltd
Priority to CN2007100204174A priority Critical patent/CN101254214B/en
Publication of CN101254214A publication Critical patent/CN101254214A/en
Application granted granted Critical
Publication of CN101254214B publication Critical patent/CN101254214B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to a matrix material for Chinese medicinal plaster, particularly to a Chinese medicinal cataplasma matrix containing Chinese medicinal extracts. The matrix comprises (by weight parts) gelatin 0.8-3, sodium carboxymethyl cellulose 4-21, polyvinylpyrrolidone 0.5-3, gum arabic 2-10, Indian gum 2-10, triethanolamine 1-6, magnesium hydroxide 0.2-2, sodium polyacrylate 2-10, carbomer 2-4, glycerol 30-50, polyvinyl alcohol 5-16, agar 0.2-2, gum tragacanth 0.5-3, colloidal silicon dioxide 2-10, sodium hydroxide 1-3, and water 20-80. The inventive matrix has the advantages of good transdermal effect, good air permeability, good affinity with various drugs, safe and environmental-friendly preparation process, no skin irritation, no anaphylaxis, comfortable application, good reusability, stable matrix properties, and no reaction with principal drug.

Description

Chinese medicine patcher substrate
Technical field
The present invention relates to a kind of host material of Chinese medicine plaster, specifically is a kind of Chinese medicine patcher substrate that adds Chinese medical concrete.
Background technology
Traditional Chinese medicine plaster is adhesively fixed by patch in use and fixes on the human body skin, and it exists many defectives: can form the solid state of glue after 1, pasting on skin, tear disadvantages such as fine hair, pain, local redness, pruritus, pimple in the time of can bringing avulsion; 2, be subjected to the restriction of patch fiber ductility, when plaster is affixed on joint part, can produce senses of discomfort such as tearing involves; 3, the permeability of medicine is bad, affects the treatment; 4, macromole, plaster that water content is low easily produce anaphylaxis in use, influence its dependability.
Summary of the invention
It is strong that technical problem to be solved by this invention provides a kind of transdermal effect, good permeability, good with the affinity of various medicines, good with the affinity of skin, manufacturing process safety, environmental protection, non-stimulated to skin, anaphylaxis is little, paste with comfortable, can take off subsides repeatedly, and the stable Chinese medicine patcher substrate of medium property.
Chinese medicine patcher substrate of the present invention, the weight proportion of its composition and each composition is: 20~80 parts in 0.8~3 part in gelatin, 4~21 parts of sodium carboxymethyl cellulose, 0.5~3 part of polyvinylpyrrolidone, 2~10 parts of arabic gums, 2~10 parts of gum ghatti, 1~6 part of triethanolamine, 0.2~1.5 part in magnesium hydroxide, 2~10 parts of sodium polyacrylate, 2~4 parts of carbomers, 30~50 parts of glycerol, 5~16 parts of polyvinyl alcohol, 0.2~2 part of agar, 0.5~3 part of tragacanth, 2~10 parts of micropowder silica gels, 1~3 part of sodium hydroxide and water.
The present invention is made up of the material of water soluble polymer frame structure, is used for the external plaster agent of percutaneous dosing approach, compares with traditional plaster to have the following advantages:
(1) high-comfort---because moistening, adhesion can be adjusted the position by local at any time microcosmic after sticking, and the use that can not influence adhesion strength and paste once more.Can on skin, not form the solid state of glue, pull disadvantages such as fine hair, pain, part redness, pruritus, pimple when not having avulsion naturally.And the main cause that the traditional just plaster of the latter is hung back the patient.
(2) high ductibility---because the non-woven fabrics that uses of dosage form is the good kind of any direction extensibility, when sticking on the big positions such as joint of mobility, mastic can stretch with the stretching, extension of joint, skin fully.Uncomfortable sensation such as removed that the tearing of forcing at joint part involves.
(3) high osmosis---this dosage form can guarantee contained drug at short notice rapid osmotic enter human body skin, and arrive local organization rapidly.What deserves to be mentioned is and since mastic in content of dispersion few, stick the back in local arthral fluid detected drug level much larger than blood Chinese medicine concentration.Illustrate that medicine is not after dependence is absorbed into blood, arrives performance drug effect in the articular cavity again; But passive epidermis, subcutaneous tissue and the articular cavity of penetrating into.
(4) high reliability---this dosage form seldom causes uncomfortable reactions such as allergy.Because ingredient is single, molecular weight is little, and compares reliability than macromole, plaster that water content is low and significantly improves.Clinical use PMS follow up survey for many years shows that reactions such as the allergy of this product only are 2.3%.
The specific embodiment
The Chinese medicine patcher base of the embodiment of the invention is made by following material composition: gelatin 0.08g, sodium carboxymethyl cellulose 0.5g, polyvinylpyrrolidone 0.3g, arabic gum 0.8g, gum ghatti 0.4g, triethanolamine 0.1g, magnesium hydroxide 0.1g, water 8ml, sodium polyacrylate 0.25g, carbomer 0.2g, glycerol 5ml, polyvinyl alcohol 1.3g, agar 0.09g, tragacanth 0.3g, micropowder silica gel 0.2g, sodium hydroxide 0.25g.
Its manufacturing process may further comprise the steps:
1, preparation solution I.The gelatin of above-mentioned consumption fully is dissolved in 60 ℃ of water, sodium carboxymethyl cellulose, polyvinylpyrrolidone, arabic gum, gum ghatti, triethanolamine, magnesium hydroxide with above-mentioned consumption adds in the gelatin solution respectively again, add water and fully dissolve, leave standstill and promptly get solution I.
2, preparation solution II.Sodium polyacrylate, carbomer, polyvinyl alcohol, agar, tragacanth, micropowder silica gel, sodium hydroxide are scattered in the glycerol, and stirring promptly gets solution II.
3, mixed solution I and solution II, and stir, catablasm base material of the present invention promptly got.

Claims (1)

1. Chinese medicine patcher substrate, it is characterized in that: the weight proportion of its composition and each composition is, 20~80 parts in 0.8~3 part in gelatin, 4~21 parts of sodium carboxymethyl cellulose, 0.5~3 part of polyvinylpyrrolidone, 2~10 parts of arabic gums, 2~10 parts of gum ghatti, 1~6 part of triethanolamine, 0.2~1.5 part in magnesium hydroxide, 2~10 parts of sodium polyacrylate, 2~4 parts of carbomers, 30~50 parts of glycerol, 5~16 parts of polyvinyl alcohol, 0.2~2 part of agar, 0.5~3 part of tragacanth, 2~10 parts of micropowder silica gels, 1~3 part of sodium hydroxide and water.
CN2007100204174A 2007-02-26 2007-02-26 Chinese medicine catablasm base material Expired - Fee Related CN101254214B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100204174A CN101254214B (en) 2007-02-26 2007-02-26 Chinese medicine catablasm base material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100204174A CN101254214B (en) 2007-02-26 2007-02-26 Chinese medicine catablasm base material

Publications (2)

Publication Number Publication Date
CN101254214A true CN101254214A (en) 2008-09-03
CN101254214B CN101254214B (en) 2010-10-06

Family

ID=39889537

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100204174A Expired - Fee Related CN101254214B (en) 2007-02-26 2007-02-26 Chinese medicine catablasm base material

Country Status (1)

Country Link
CN (1) CN101254214B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101947322A (en) * 2010-09-03 2011-01-19 南方医科大学 Gel patch matrix and preparation method and application thereof
CN104224979A (en) * 2014-07-23 2014-12-24 江苏七〇七天然制药有限公司 Traditional Chinese medicine cataplasm for treating emphysema by plastering on acupoints and preparation method thereof
CN113440590A (en) * 2021-07-30 2021-09-28 无锡市锡山区中医医院 Toad stamen ointment
CN113713113A (en) * 2021-09-28 2021-11-30 四川大学 Composition for treating oral mucosa diseases and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1215831C (en) * 2003-10-08 2005-08-24 西安千禾药业有限责任公司 Chinese medicine cataplasm matrix and preparing technique thereof
CN1215880C (en) * 2003-10-21 2005-08-24 沈阳东陵药业股份有限公司 Water-soluble matrix for external transdermal paster and preparing method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101947322A (en) * 2010-09-03 2011-01-19 南方医科大学 Gel patch matrix and preparation method and application thereof
CN101947322B (en) * 2010-09-03 2012-07-04 南方医科大学 Gel patch matrix and preparation method and application thereof
CN104224979A (en) * 2014-07-23 2014-12-24 江苏七〇七天然制药有限公司 Traditional Chinese medicine cataplasm for treating emphysema by plastering on acupoints and preparation method thereof
CN104224979B (en) * 2014-07-23 2018-01-16 江苏七O七天然制药有限公司 Chinese medicine patcher of acupoint application treatment pulmonary emphysema and preparation method thereof
CN113440590A (en) * 2021-07-30 2021-09-28 无锡市锡山区中医医院 Toad stamen ointment
CN113440590B (en) * 2021-07-30 2022-07-12 无锡市锡山区中医医院 External toad stamen ointment for treating cancer pain
CN113713113A (en) * 2021-09-28 2021-11-30 四川大学 Composition for treating oral mucosa diseases and preparation method thereof
CN113713113B (en) * 2021-09-28 2023-09-19 四川护家卫士生物医药科技有限公司 Composition for treating oral mucosa diseases and preparation method thereof

Also Published As

Publication number Publication date
CN101254214B (en) 2010-10-06

Similar Documents

Publication Publication Date Title
AU2018347514B2 (en) Methods and compositions for topical delivery
Nagai Adhesive topical drug delivery system
Patil et al. A review on topical gels as drug delivery system
US5731303A (en) Transdermal and trans-membrane delivery compositions
US3891757A (en) Anaesthetic topical and percutaneous administration with selected promoters
JP2671248B2 (en) Method for enhancing the penetration of medicinal or cosmetic ingredients
DE60018797T2 (en) HYDROXIDE RELEASING COMPOUNDS TO IMPROVE SKIN PERMEABILITY
AU770516B2 (en) Polyoxyalkylene copolymers containing pourable liquid vehicles
DE69524614T2 (en) MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION
EP3442488A1 (en) Compositions for topical application of compounds
Lin et al. Salicylic acid revisited.
WO2006038315A1 (en) Preparation for percutaneous/permucosal absorption
Mehta Topical and transdermal drug delivery: what a pharmacist needs to know
CN101254214B (en) Chinese medicine catablasm base material
US3968245A (en) Sympathomimetic topical and percutaneous administration with halogenated promoters
CN106821963A (en) A kind of method of utilization cellulose base temperature and the load of pH sensitive hydrogels and slow releasing pharmaceutical
CN107029343B (en) A kind of portable cutaneous penetration patch instrument and preparation method thereof
US3787571A (en) Trichloroethanol and trifluoroethanol topical and percutaneous steroid adsorption promoters
AU637860B2 (en) Penetration enhancement with multi-component system of n-aliphatic pyrrolidones with lower alcohols
CN101254215A (en) Preparing method of Chinese medicine catablasm base material
WO2024035832A1 (en) Topical product hands-free applicator drug delivery system and methods of making and using the same
CN100482210C (en) External applied Chinese medicinal paste for treating arthralgia
US4476115A (en) Analgesic composition and method of treating subdermal pain
Sonkar et al. A review on transdermal patches as a novel drug delivery system
KR100192149B1 (en) Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101006

Termination date: 20160226